Onyvax-P: Completed Phase IIb enrollment

Onyvax completed enrollment of 75 patients in a placebo-controlled, European Phase llb (ONY-P1-06-01) trial evaluating 15 doses of intradermal Onyvax-P given over the course of 12 months. ...